Financials
- Market Capitalization 679.43 M
- Employee 73
- Founded 2005
- CEO Jason Okazaki
- Website www.assemblybio.com
- Headquarter Delaware, United States
- FIGI BBG000R62Q06
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-61.84
ratio cours/chiffre d'affaires
5.27
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2707 | ALLO Allogene Therapeutics, Inc. - Common Stock | 2.03 USD | -2.87% | -4.25% | +16.67% | +72.03% | 701.35 M USD | ||
| 2716 | ZVRA Zevra Therapeutics, Inc. - Common Stock | 11.60 USD | -2.11% | -2.52% | +19.34% | +9.02% | 688.85 M USD | ||
| 2742 | HELP Cybin Inc. - Common Stock | 12.26 USD | -7.40% | -3.99% | +61.74% | +36.68% | 633.01 M USD | ||
| 2746 | VSTM Verastem, Inc. - Common Stock | 7.20 USD | -2.44% | +3.60% | +15.38% | -22.25% | 652.06 M USD |